Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis

Igor Bado, Fotis Nikolos, Gayani Rajapaksa, Wanfu Wu, Jessica Castaneda, Savitri Krishnamurthy, Paul Webb, Jan Åke Gustafsson, Christoforos Thomas

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Background: Upregulation of estrogen receptor beta (ERβ) in breast cancer cells is associated with epithelial maintenance, decreased proliferation and invasion, and a reduction in the expression of the receptor has been observed in invasive breast tumors. However, proof of an association between loss of ERβ and breast carcinogenesis is still missing. Methods: To study the role of ERβ in breast oncogenesis, we generated mouse conditional mutants with specific inactivation of ERβ and p53 in the mammary gland epithelium. For epithelium-specific knockout of ERβ and p53, ERβ F/F and p53 F/F mice were crossed to transgenic mice that express the Cre recombinase under the control of the human keratin 14 promoter. Results: Somatic loss of ERβ significantly accelerated formation of p53-deficient mammary tumors. Loss of the receptor also resulted in the development of less differentiated carcinomas with stronger spindle cell morphology and decreased expression of luminal epithelial markers. Conclusions: Our results show that synergism between ERβ and p53 inactivation functions to determine important aspects of breast oncogenesis and cancer progression.

Original languageEnglish
Article number79
JournalBreast Cancer Research
Issue number1
StatePublished - 3 Jul 2017
Externally publishedYes


  • Breast cancer
  • Breast carcinogenesis
  • Estrogen receptor beta
  • Genetically engineered mice
  • P53


Dive into the research topics of 'Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis'. Together they form a unique fingerprint.

Cite this